Brief: Synlogic Announces Decision To Discontinue Synpheny-3 Study And Provides Corporate Update

Synlogic

08/02/2024 23:20

Feb 8 (Reuters) - Synlogic Inc  SYBX.O :
    * SYNLOGIC ANNOUNCES DECISION TO DISCONTINUE SYNPHENY-3
STUDY
AND PROVIDES CORPORATE UPDATE
    * SYNLOGIC INC: DATA REVIEW FOUND TREATMENT TO BE SAFE AND
WELL-TOLERATED
    * SYNLOGIC INC: BOARD OF DIRECTORS PLANS TO PERFORM
ASSESSMENT OF
STRATEGIC OPTIONS
    * SYNLOGIC INC: DECISION TO END TRIAL FOLLOWS INTERNAL
REVIEW OF
INITIAL DATA INDICATING STUDY UNLIKELY TO MEET PRIMARY ENDPOINT
    * SYNLOGIC INC - SYNLOGIC WILL CEASE OPERATIONS, AND REDUCE
ITS
WORKFORCE BY MORE THAN 90%,
    * SYNLOGIC INC - MAJORITY OF IMPACTED ROLES WILL END IN
FEBRUARY
2024
    * SYNLOGIC INC: AOIFE BRENNAN IS ALSO DEPARTING AS PRESIDENT
AND
CHIEF EXECUTIVE OFFICER
    * SYNLOGIC INC - OUR CASH, CASH EQUIVALENTS AND SHORT-TERM
INVESTMENTS BALANCE AT DECEMBER 31, 2023 WAS $47.7 MILLION

Source text for Eikon:  ID:nGNX2Q47rZ 
Further company coverage:  SYBX.O 

 ((reuters.briefs@thomsonreuters.com;))